8 Result(s)
within
Nava Siegelmann-Danieli
English
-
Article
Open AccessThe reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer
In this article, we focus on the reimbursement process, and as an example, characterize the time to reimbursement of pembrolizumab, a PD-1 immune checkpoint inhibitor for treatment of metastatic NSCLC from public...
-
Article
Breast cancer survivors: physical and mental quality of life 10 years following diagnosis, a case-control study
Improvements in diagnosis and treatment of Breast Cancer (BC) have resulted in an increase in the life expectancy of survivors and in the importance of quality of life in BC survivorship care. The current stud...
-
Article
Open AccessDoes levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective
To evaluate the association between levonorgestrel-releasing intrauterine system (LNG-IUS) use and breast cancer (BC) risk.
-
Article
Primary prevention and screening practices among long-term breast cancer survivors
Parallel to increasing survival of breast cancer (BC) patients, a need has arisen to characterize the follow-up required to improve and maintain their health. Our study aimed to assess changes in lifestyle hab...
-
Article
Open AccessTrends in annual drug expenditure – a 16 year perspective of a public healthcare maintenance organization
Modern drug therapy accounts for a major share of health expenditure and challenges public provider resources. The objective of our study was to compare drug expenditure trends for ten major drug classes over ...
-
Article
Identification of health care needs of long-term breast cancer survivors among Israeli women
Improvement in treatment has extended survival of breast cancer patients. Our study aimed to characterize health service use among long-term breast cancer survivors in Israel in order to identify and address s...
-
Article
Resilience and Psychosocial Adjustment in Digestive System Cancer
The study aims to investigate the contributions of resilience, affective reactions and post traumatic growth (PTG) to psychosocial adjustment and behavioral changes among digestive system cancer patients in Is...
-
Article
Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen
Endoxifen, the most active metabolite of the prodrug tamoxifen, is produced by cytochrome P450 CYP2D6. Breast cancer patients treated with tamoxifen who have reduced CYP2D6 activity, related to either genetic ...
